36
Views
12
CrossRef citations to date
0
Altmetric
Review

Estrogen receptor-mediated neuroprotection: The role of the Alzheimer’s disease-related gene seladin-1

&
Pages 817-824 | Published online: 08 Aug 2008

References

  • Abad-RodriguezJLedesmaMDCraessaertsKNeuronal membrane cholesterol loss enhance amyloid peptide generationJ Cell Biol20041679536015583033
  • ArbogastLAEstrogen genomic and membrane actions at an intersectionTrends Endocrinol Metab2008191218023201
  • ArispeNDohMPlasma membrane cholesterol controls the cytotoxicity of Alzheimer’s disease AbetaP (1–40) and (1–42) peptidesFASEB J20021615263612374775
  • BarniTMaggiMFantoniGSex steroids and odorants modulate gonadotropin-releasing hormone secretion in primary cultures of human olfactory cellsJ Clin Endocrinol Metab19998442667310566683
  • BehlCEstrogen can protect neurons: modes of actionJ Steroid Biochem Mol Biol20038319519712650716
  • BenvenutiSLucianiPVannelliGBEstrogen and SERMs exert neuroprotective effects and stimulate the expression of seladin-1, a recently discovered anti-apoptotic gene, in human neuroblast long-term cell culturesJ Clin Endocrinol Metab20059017758215585566
  • DhandapaniKMBrannDWProtective effects of estrogen and selective estrogen receptor modulators in the brainBiol Reprod20026713798512390866
  • DubalDBZhuHYuJEstrogen receptor alpha, not beta, is a critical link in esradiol-mediated protection against brain injueryProc Natl Acad Sci USA20019819525711172057
  • FillitHMThe role of hormone replacement therapy in the prevention of Alzheimer’s diseaseArch Intern Med200216219344212230415
  • FitzpatrickDRKeelingJWEvansMJClinical phenotype of desmosterolosisAm J Med Genet199875145529450875
  • GreeveIHermans-BorgmeyerIBrellingerCThe human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer’s disease-associated neurodegeneration and oxidative stressJ Neurosci20012073455211007892
  • HarringtonWRShengSBarnettDHActivities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepressionMol Cell Endocrinol2003206132212943986
  • HawkinsMBThorntonJWCrewsDIdentification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleostsProc Natl Acad Sci USA20009710751611005855
  • HermanGEDisorders of cholesterol biosynthesis: prototypic metabolic malformation syndromesHum Mol Genet200312Spec No 1R758812668600
  • HuXYQinSLuYPDecreased estrogen receptor-α expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patientsActa Neuropathol20031062132012819990
  • IivonenSHiltunenMAlafuzoffISeladin-1 transcription is linked to neuronal degeneration in Alzheimer’s diseaseNeuroscience20021133011012127087
  • MacLuskyNJEstrogen and Alzheimer’s disease: the apolipoprotein connectionEndocrinology20041453062415198969
  • MaggiACianaPBelcreditoSEstrogens in the nervous system:mechanisms and nonreproductive functionsAnn Rev Physiol20046629131314977405
  • MirzaRHayasakaSTakagishiYDHCR24 gene knockout mice demonstrate lethal dermopathy with differentiation and maturation defects in the epidermisJ Invest Dermatol20061266384716410790
  • LucianiPDeleddaCRosatiFSeladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell culturesEndocrinology2008 Equb ahead of print
  • O’NeillKChenSBrintonRDImpact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer’s diseaseExp Neurol2004a1856380
  • O’NeillKChenSBrintonRDImpact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer’s diseaseExp Neurol2004b18826878
  • Paganini-HillAHendersonVWEstrogen deficiency and risk of Alzheimer’s disease in womenAm J Epidemol199414025661
  • PuglielliLTanziREKovacsDMAlzheimer’s disease: the cholesterol connectionNat Neurosci200363455112658281
  • RappSREspelandMAShumakerSAEffect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trialJAMA200328926637212771113
  • ReissABSillerKARahmanMMCholesterol in neurologic disorders of the elderly: stroke and Alzheimer’s diseaseNeurobiol Aging2004259778915212822
  • ResnickSMHendersonVWHormone therapy and risk of Alzheimer diseaseJAMA20022882170212413378
  • SchumacherMGuennounRGhoumaruANovel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous systemEnd Rev200728387439
  • SelkoeDJAlzheimer’s disease: genes, proteins, and therapyPhysiol Rev2001817417611274343
  • ShumakerSALegaultCRappSREstrogen plus progestin and the incidence of dementia and mild cognitive impairment in post-menopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trialJAMA200328926516212771112
  • Toran-AllerandCDMinireview: a plethora of estrogen receptors in the brain:where will it end?Endocrinology200414510697414670986
  • TurgeonJLCarrMCMakiPMComplex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studiesEnd Rev200627576605
  • VannelliGBEnsoliFZonefratiRNeuroblast long-term cell cultures from human fetal olfactory epithelium respond to odorsJ Neurosci199515428294
  • WangLAnderssonSWarnerMMorphological abnormalities in the brains of estrogen receptor beta knockout miceProc Natl Acad Sci USA2001982792611226319
  • WaterhamHRKosterJRomeijnGJMutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesisAm J Hum Genet2001696859411519011
  • WechslerABrafmanAShafirMGeneration of viable cholesterol-free miceScience2003302208714684813
  • WuCMiloslavskayaIDemontisSRegulation of cellular response to oncogenic and oxidative stress by Seladin-1Nature2004432640515577914
  • YaffeKKruegerKCummingsSREffect of raloxifene on prevention of dementia and cognitive imparirment in older women: the Multiple Outcome of Raloxifene Evaluation (MORE) randomized trialAm J Psychiatry20051626839015800139
  • YanagisawaKCholesterol and pathological processes in Alzheimer’s diseaseJ Neurosci Res200270361612391598
  • ZandiPPCarlsonMCPlassmanBLHormone replacement therapy and incidence of Alzheimer disease in older womenJAMA20022882123912413371